SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.
The SeaSpine ticker is SPNE and it is traded on the NASDAQ exchange.
SeaSpine does not currently have a direct stock purchase plan.
SeaSpine was incorporated on February 12, 2015 as a direct, wholly owned subsidiary of Integra LifeSciences Corporation, a NASDAQ-listed company that is a world leader in medical technology.
On October 29, 2014, Integra’s board of directors approved a plan to separate SeaSpine from Integra. The spin-off was effective July 1, 2015, the distribution date for the spin-off, with 100 percent of the shares of SeaSpine distributed to Integra shareholders.
SeaSpine common stock commenced trading publicly on July 2, 2015; the first day following the distribution date.
The annual meeting of stockholders was held at the offices of SeaSpine in Carlsbad, on Wednesday, June 3, 2020 at 7:00 a.m. local time. The meeting for 2021 is scheduled for Wednesday, June 2, 2021 at 7:00 a.m. local time.
SeaSpine does not currently expect to declare or pay any cash or other dividends on its common stock, and intends to reinvest cash flow generated by operations in its business.
SeaSpine uses American Stock Transfer & Trust Company, LLC as its transfer agent. You can contact them by mail at 6201 15th Avenue, Brooklyn, New York 11219 or by phone at (800) 937-5449.
You can view SeaSpine’s Board of Directors by visiting the Board of Directors section of the Investor Relations section of the SeaSpine website.
You can view profiles of the management team by visiting the Management section of the Investor Relations section of the SeaSpine website.
SeaSpine’s policy is to issue a press release that includes the date of its quarterly earnings call. When the release is issued, it will be posted on the “Events & Presentations” section of the IR website along with the details for a conference and/or webcast to discuss the results.
You can contact SeaSpine Investor Relations via email at:
In addition, you can reach Investor Relations by calling (415) 513-1281.
5770 Armada Dr, Carlsbad, CA 92008, Phone: (760) 727-8399
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent: American Stock Transfer & Trust Company, LLC. You can contact them by mail at 6201 15th Avenue, Brooklyn, New York 11219 or by phone at (800) 937-5449.
If you hold stock certificates in your name, please contact SeaSpine’s transfer agent regarding the replacement of lost certificates: American Stock Transfer & Trust Company, LLC. You can contact them by mail at 6201 15th Avenue, Brooklyn, New York 11219 or by phone at (800) 937-5449.